NCT02230956View on ClinicalTrials.gov

BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Osteoarthritis
Interventions
BIOLOGICAL

onabotulinumtoxinA

onabotulinumtoxinA (botulinum toxin Type A) injection into the intra-articular space of the study knee.

DRUG

Normal Saline

Normal Saline (placebo) injection into the intra-articular space of the study knee.

Trial Locations (3)

Unknown

Artesia

Pardubice

Vejle

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY